Clocortolone pivalate

Revision as of 15:11, 18 February 2015 by Alberto Plate (talk | contribs) (Created page with "{{DrugProjectFormSinglePage |authorTag={{AP}} |genericName=Clocortolone pivalate |aOrAn=a |drugClass=corticosteroid |indicationType=treatment |indication=inflammatory and...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Clocortolone pivalate
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alberto Plate [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Clocortolone pivalate is a corticosteroid that is FDA approved for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Common adverse reactions include dry skin, pruritus, burning sensation and irritation symptoms.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

There is limited information regarding Clocortolone pivalate FDA-Labeled Indications and Dosage (Adult) in the drug label.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Clocortolone pivalate in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Clocortolone pivalate in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Clocortolone pivalate FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Clocortolone pivalate in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Clocortolone pivalate in pediatric patients.

Contraindications

Warnings

  • Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glycosuria in some patients.
  • Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings.
  • Therefore, patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests. If HPA axis suppression is noted, an attempt should be made to withdraw the drug,to reduce the frequency of application, or to substitute a less potent steroid.
  • Recovery of HPA axis function is generally prompt and complete upon discontinuation of the drug. In frequently, signs and symptoms of steroid withdrawal may occur, requiring supplemental systemic corticosteroids.
  • Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity.
  • If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted.
  • In the presence of dermatological infections, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.

Adverse Reactions

Clinical Trials Experience

The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence:

Postmarketing Experience

There is limited information regarding Clocortolone pivalate Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Clocortolone pivalate Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Clocortolone pivalate in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Clocortolone pivalate in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Clocortolone pivalate during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Clocortolone pivalate in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Clocortolone pivalate in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Clocortolone pivalate in geriatric settings.

Gender

There is no FDA guidance on the use of Clocortolone pivalate with respect to specific gender populations.

Race

There is no FDA guidance on the use of Clocortolone pivalate with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Clocortolone pivalate in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Clocortolone pivalate in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Clocortolone pivalate in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Clocortolone pivalate in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Clocortolone pivalate Administration in the drug label.

Monitoring

There is limited information regarding Clocortolone pivalate Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Clocortolone pivalate and IV administrations.

Overdosage

There is limited information regarding Clocortolone pivalate overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Clocortolone pivalate Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Clocortolone pivalate Mechanism of Action in the drug label.

Structure

There is limited information regarding Clocortolone pivalate Structure in the drug label.

Pharmacodynamics

There is limited information regarding Clocortolone pivalate Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Clocortolone pivalate Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Clocortolone pivalate Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Clocortolone pivalate Clinical Studies in the drug label.

How Supplied

There is limited information regarding Clocortolone pivalate How Supplied in the drug label.

Storage

There is limited information regarding Clocortolone pivalate Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Clocortolone pivalate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Clocortolone pivalate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Clocortolone pivalate Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Clocortolone pivalate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Clocortolone pivalate Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Clocortolone pivalate Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.